Skip to main content

Table 2 Multivariable analysis for DFS in the training cohort

From: Radiomics predicts the prognosis of patients with locally advanced breast cancer by reflecting the heterogeneity of tumor cells and the tumor microenvironment

Variables

HR

95% CI

p value

Age

1.0431

1.006–1.082

0.024

cTNM stage

   

IIIa-b vs II

1.6461

0.685–3.957

0.265

IIIc vs II

1.8162

0.622–5.302

0.275

pCR (Yes vs No)

1.229

0.4647–3.248

0.678

IMNI (Yes vs No)

0.724

0.284–1.845

0.498

HR (HR + vs HR −)

0.742

0.301–1.829

0.516

HER2 (HER2 + vs HER2 −)

0.688

0.285–1.664

0.407

Radiomics score

3.866

2.537–5.891

 < 0.001

  1. HR hormonal receptor, HER2 human epidermal growth factor receptor 2, IMNI internal mammary node irradiation